Gemtuzumab(CMA-676) is a monoclonal antibody directed against the CD33 antigen and consists of a recombinant humanized IgG4 antibody.Gemtuzumab can be used to synthesize Gemtuzumab ozogamicin, an antibody coupled compound (ADC) Gemtuzumab is used in the study of acute myeloid leukemia.
Molecular Weight:
145.2 kDa
Purity:
98.50%
CAS Number:
[2924764-21-4]
Target:
ADC Antibody
T9901A-003
* VAT and and shipping costs not included. Errors and price changes excepted